Patents matching “ras”

US 10711007

Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

Prelude Therapeutics, Incorporated · Granted Jul 14, 2020 · Expires Jul 9, 2040

US 10689377

KRas G12C inhibitors

Mirati Therapeutics, Inc. · Granted Jun 23, 2020 · Expires Jun 18, 2040

US 10668107

Methods of transdifferentiation and methods of use thereof

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jun 2, 2020 · Expires May 28, 2040

US 10647715

KRas G12C inhibitors

Mirati Therapeutics, Inc. · Granted May 12, 2020 · Expires May 7, 2040

US 10647964

Non-neuroinvasive viruses and uses thereof

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted May 12, 2020 · Expires May 7, 2040

AR 113437

INHIBIDORES MITOCONDRIALES PARA EL TRATAMIENTO DE TRASTORNOS DE PROLIFERACIÓN

BASILEA PHARM INT AG [CH] · Granted May 6, 2020 · Expires May 1, 2040

US 10639350

Methods and pharmaceutical compositions for improving wound healing using CD24

The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted May 5, 2020 · Expires Apr 30, 2040

US 10633381

KRas G12C inhibitors

Mirati Therapeutics, Inc. · Granted Apr 28, 2020 · Expires Apr 23, 2040

US 10633643

Engineered Clostridium botulinum toxin adapted to deliver molecules into selected cells

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Apr 28, 2020 · Expires Apr 23, 2040

US 10632088

Inactivators of Toxoplasma gondii ornithine aminotransferase for treating toxoplasmosis and malaria

Northwestern University · Granted Apr 28, 2020 · Expires Apr 23, 2040

US 10611816

Anti-KRAS-G12D T cell receptors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 7, 2020 · Expires Apr 2, 2040

US 10591468

Circulating antibodies against MAA adducts as biomarker for coronary artery disease

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Mar 17, 2020 · Expires Mar 12, 2040

US 10584389

Cancer screening by detection of ultrastructural and molecular markers

Northwestern University · Granted Mar 10, 2020 · Expires Mar 5, 2040

US 10568901

Micro-RNA for the treatment of malignant solid tumors and metastasis

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Feb 25, 2020 · Expires Feb 20, 2040

US 10570140

Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

Prelude Therapeutics, Incorporated · Granted Feb 25, 2020 · Expires Feb 20, 2040

US 10555963

Klotho protein and related compounds for the treatment and diagnosis of cancer

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Feb 11, 2020 · Expires Feb 6, 2040

US 10556940

T cell receptors recognizing HLA-Cw8 restricted mutated KRAS

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 11, 2020 · Expires Feb 6, 2040

US 10532056

Therapeutic compositions, combinations, and methods of use

VERASTEM, INC. · Granted Jan 14, 2020 · Expires Jan 9, 2040

US 10532109

Peptide-DNA chimeras for treatment of HER overexpressing cancers

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jan 14, 2020 · Expires Jan 9, 2040

US 10531680

Creatine ester pronutrient compounds and formulations

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jan 14, 2020 · Expires Jan 9, 2040

US 10508136

Peptides and compositions for prevention of cell adhesion and methods of using same

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Dec 17, 2019 · Expires Dec 12, 2039

US 10485800

Mixed lineage kinase inhibitors for HIV/AIDS therapies

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Nov 26, 2019 · Expires Nov 21, 2039

US 10485809

Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Nov 26, 2019 · Expires Nov 21, 2039

US 10471055

Methods of treating cancer patients with farnesyltransferase inhibitors

Kura Oncology, Inc. · Granted Nov 12, 2019 · Expires Nov 7, 2039